Mono and biallelic variants in HCN2 cause severe neurodevelopmental disorders.
Clara HoudayerA Marie PhillipsMarie ChabbertJennifer BourreauReza MaroofianHenry HouldenKay RichardsNebal Waill SaadiEliška Dad'ováPatrick Van BogaertMailys RupinBoris KerenPerrine CharlesThomas SmolAudrey RiquetLynn S PaisAnne H O'Donnell-LuriaGrace E VanNoyAllan BayatRikke Steensjerre MollerKern OlofssonRami Abou JamraSteffen SyrbeMajed DasoukiLaurie H SeaverJennifer A SullivanVandana ShashiFowzan Sami AlkurayaAlexis F PossJ Edward SpenceRhonda E SchnurIan C ForsterChaseley E McKenzieCas SimonsMin WangPenny SnellRussell C DaleMichael BuckleyTony RoscioliNoha ElserafyBenjamin DauriatVincent ProcaccioHenrion DanielGuy LenaersEstelle ColinNienke E VerbeekKoen L Van GassenClaire LegendreDominique BonneauChristopher A ReidKatherine B HowellAlban ZieglerChristian LegrosPublished in: medRxiv : the preprint server for health sciences (2024)
Hyperpolarization activated Cyclic Nucleotide (HCN) gated channels are crucial for various neurophysiological functions, including learning and sensory functions, and their dysfunction are responsible for brain disorders, such as epilepsy. To date, HCN2 variants have only been associated with mild epilepsy and recently, one monoallelic missense variant has been linked to developmental and epileptic encephalopathy. Here, we expand the phenotypic spectrum of HCN2- related disorders by describing twenty-one additional individuals from fifteen unrelated families carrying HCN2 variants. Seventeen individuals had developmental delay/intellectual disability (DD/ID), two had borderline DD/ID, and one had borderline DD. Ten individuals had epilepsy with DD/ID, with median age of onset of 10 months, and one had epilepsy with normal development. Molecular diagnosis identified thirteen different pathogenic HCN2 variants, including eleven missense variants affecting highly conserved amino acids, one frameshift variant, and one in-frame deletion. Seven variants were monoallelic of which five occurred de novo, one was not maternally inherited, one was inherited from a father with mild learning disabilities, and one was of unknown inheritance. The remaining six variants were biallelic, with four homozygous and two compound heterozygous variants. Functional studies using two-electrode voltage-clamp recordings in Xenopus laevis oocytes were performed on three monoallelic variants, p.(Arg324His), p.(Ala363Val), and p.(Met374Leu), and three biallelic variants, p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp). The p.(Arg324His) variant induced a strong increase of HCN2 conductance, while p.(Ala363Val) and p.(Met374Leu) displayed dominant negative effects, leading to a partial loss of HCN2 channel function. By confocal imaging, we found that the p.(Leu377His), p.(Pro493Leu) and p.(Gly587Asp) pathogenic variants impaired membrane trafficking, resulting in a complete loss of HCN2 elicited currents in Xenopus oocytes. Structural 3D-analysis in depolarized and hyperpolarized states of HCN2 channels, revealed that the pathogenic variants p.(His205Gln), p.(Ser409Leu), p.(Arg324Cys), p.(Asn369Ser) and p.(Gly460Asp) modify molecular interactions altering HCN2 function. Taken together, our data broadens the clinical spectrum associated with HCN2 variants, and disclose that HCN2 is involved in developmental encephalopathy with or without epilepsy.